Thuany Silva Santos, Kely Hernandéz Galvis, Sergio Vañó Galván, David Saceda-Corralo
International journal of dermatology 2021 NovIt is estimated that chemotherapy-induced alopecia (CIA) occurs in 65% of chemotherapeutic patients. Forty-seven percent of cancer patients consider hair loss to be the most traumatic aspect of therapy. CIA can be anticipated, depending on the regimen used, and doctors should be aware of the treatments that can minimize it. Careful evaluation before chemotherapy treatment should be performed, and trichoscopy may be useful. Dermatologists do not generally evaluate postchemotherapy alopecia. However, there is an increasing number of reports of permanent chemotherapy-induced alopecia, and these patients require treatment. © 2021 the International Society of Dermatology.
Thuany Silva Santos, Kely Hernandéz Galvis, Sergio Vañó Galván, David Saceda-Corralo. Post-chemotherapy alopecia: what the dermatologist needs to know. International journal of dermatology. 2021 Nov;60(11):1313-1317
PMID: 34348414
View Full Text